Teraplast Statistics
Total Valuation
Teraplast has a market cap or net worth of RON 1.08 billion. The enterprise value is 1.42 billion.
Market Cap | 1.08B |
Enterprise Value | 1.42B |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Teraplast has 2.18 billion shares outstanding.
Shares Outstanding | 2.18B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 46.95% |
Owned by Institutions (%) | 15.37% |
Float | 942.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.38 |
PB Ratio | 3.55 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.02, with an EV/FCF ratio of -17.98.
EV / Earnings | -279.03 |
EV / Sales | 1.82 |
EV / EBITDA | 27.02 |
EV / EBIT | 126.17 |
EV / FCF | -17.98 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.13.
Current Ratio | 1.12 |
Quick Ratio | 0.59 |
Debt / Equity | 1.13 |
Debt / EBITDA | 6.63 |
Debt / FCF | -4.41 |
Interest Coverage | 0.71 |
Financial Efficiency
Return on equity (ROE) is -1.45% and return on invested capital (ROIC) is 1.18%.
Return on Equity (ROE) | -1.45% |
Return on Assets (ROA) | 0.83% |
Return on Capital (ROIC) | 1.18% |
Revenue Per Employee | 813,885 |
Profits Per Employee | -5,300 |
Employee Count | 959 |
Asset Turnover | 0.92 |
Inventory Turnover | 3.00 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.54% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -4.54% |
50-Day Moving Average | 0.50 |
200-Day Moving Average | 0.55 |
Relative Strength Index (RSI) | 51.49 |
Average Volume (20 Days) | 521,574 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Teraplast had revenue of RON 780.52 million and -5.08 million in losses. Loss per share was -0.00.
Revenue | 780.52M |
Gross Profit | 274.54M |
Operating Income | 11.24M |
Pretax Income | 654,735 |
Net Income | -5.08M |
EBITDA | 47.63M |
EBIT | 11.24M |
Loss Per Share | -0.00 |
Balance Sheet
The company has 12.63 million in cash and 347.91 million in debt, giving a net cash position of -335.27 million or -0.15 per share.
Cash & Cash Equivalents | 12.63M |
Total Debt | 347.91M |
Net Cash | -335.27M |
Net Cash Per Share | -0.15 |
Equity (Book Value) | 308.70M |
Book Value Per Share | 0.14 |
Working Capital | 48.79M |
Cash Flow
In the last 12 months, operating cash flow was 29.31 million and capital expenditures -108.20 million, giving a free cash flow of -78.89 million.
Operating Cash Flow | 29.31M |
Capital Expenditures | -108.20M |
Free Cash Flow | -78.89M |
FCF Per Share | -0.04 |
Margins
Gross margin is 35.17%, with operating and profit margins of 1.44% and -0.65%.
Gross Margin | 35.17% |
Operating Margin | 1.44% |
Pretax Margin | 0.08% |
Profit Margin | -0.65% |
EBITDA Margin | 6.10% |
EBIT Margin | 1.44% |
FCF Margin | -10.11% |
Dividends & Yields
Teraplast does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -0.47% |
FCF Yield | -7.32% |
Stock Splits
The last stock split was on September 28, 2021. It was a forward split with a ratio of 1.25.
Last Split Date | Sep 28, 2021 |
Split Type | Forward |
Split Ratio | 1.25 |
Scores
Teraplast has an Altman Z-Score of 2.05. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.05 |
Piotroski F-Score | n/a |